Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 790605, 7 pages
http://dx.doi.org/10.1155/2010/790605
Research Article

Circulating Levels of Inflammatory Markers in Intrauterine Growth Restriction

1Neonatal Division, Second Department of Obstetrics and Gynecology, University of Athens, 11528 Athens, Greece
2Department of Clinical Biochemistry, “Aghia Sophia” Children’s Hospital, 11527 Athens, Greece
3First Department of Pediatrics, University of Athens, 11527 Athens, Greece

Received 31 October 2009; Revised 25 February 2010; Accepted 24 March 2010

Academic Editor: Hidde Bult

Copyright © 2010 Theodora Boutsikou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Brodsky and H. Christou, “Current concepts in intrauterine growth restriction,” Journal of Intensive Care Medicine, vol. 19, no. 6, pp. 307–319, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Sankaran and P. M. Kyle, “Aetiology and pathogenesis of IUGR,” Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 23, no. 6, pp. 765–777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. B. Metcalfe and P. Monaghan, “Compensation for a bad start: grow now, pay later?” Trends in Ecology and Evolution, vol. 16, no. 5, pp. 254–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Leon, I. Koupilova, H. O. Lithell et al., “Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men,” British Medical Journal, vol. 312, no. 7028, pp. 401–406, 1996. View at Google Scholar · View at Scopus
  5. J. G. Eriksson, T. Forsén, J. Tuomilehto, P. D. Winter, C. Osmond, and D. J. P. Barker, “Catch-up growth in childhood and death from coronary heart disease: longitudinal study,” British Medical Journal, vol. 318, no. 7181, pp. 427–431, 1999. View at Google Scholar · View at Scopus
  6. D. J. Rader, “Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus,” American Journal of Medicine, vol. 120, no. 3, supplement 1, pp. S12–S18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Reaven, “Why a cluster is truly a cluster: insulin resistance and cardiovascular disease,” Clinical Chemistry, vol. 54, no. 5, pp. 785–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. B. Meigs, M. K. Rutter, L. M. Sullivan, C. S. Fox, R. B. D'Agostino Sr., and P. W. F. Wilson, “Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome,” Diabetes Care, vol. 30, no. 5, pp. 1219–1225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Reaven, “Banting lecture 1988. Role of insulin resistance in human disease,” Diabetes, vol. 37, no. 12, pp. 1595–1607, 1988. View at Google Scholar
  10. K. Park, M. Steffes, D.-H. Lee, J. H. Himes, and D. R. Jacobs Jr., “Association of inflammation with worsening HOMA-insulin resistance,” Diabetologia, vol. 52, no. 11, pp. 2337–2344, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Deepa, K. Velmurugan, K. Arvind et al., “Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance—the Chennai Urban Rural Epidemiology Study (CURES),” Metabolism, vol. 55, no. 9, pp. 1232–1238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. C. S. Yajnik, “Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries,” Journal of Nutrition, vol. 134, no. 1, pp. 205–210, 2004. View at Google Scholar · View at Scopus
  13. C. S. Yajnik, H. G. Lubree, S. S. Rege et al., “Adiposity and hyperinsulinemia in Indians are present at birth,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5575–5580, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Otero, R. Lago, F. Lago et al., “Leptin, from fat to inflammation: old questions and new insights,” FEBS Letters, vol. 579, no. 2, pp. 295–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lappas, M. Permezel, and G. E. Rice, “Leptin and adiponectin stimulate the release of proinflammatory cytokines and prostaglandins from human placenta and maternal adipose tissue via nuclear factor-κB, peroxisomal proliferator-activated receptor-γ and extracellularly regulated kinase 1/2,” Endocrinology, vol. 146, no. 8, pp. 3334–3342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Mostyn, D. H. Keisler, R. Webb, T. Stephenson, and M. E. Symonds, “The role of leptin in the transition from fetus to neonate,” Proceedings of the Nutrition Society, vol. 60, no. 2, pp. 187–194, 2001. View at Google Scholar · View at Scopus
  17. A. Malamitsi-Puchner, D. D. Briana, M. Boutsikou, E. Kouskouni, D. Hassiakos, and D. Gourgiotis, “Perinatal circulating visfatin levels in intrauterine growth restriction,” Pediatrics, vol. 119, no. 6, pp. e1314–e1318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Antuna-Puente, B. Feve, S. Fellahi, and J.-P. Bastard, “Adipokines: the missing link between insulin resistance and obesity,” Diabetes and Metabolism, vol. 34, no. 1, pp. 2–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. F. Mortensen, “C-reactive protein, inflammation, and innate immunity,” Immunologic Research, vol. 24, no. 2, pp. 163–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. T. W. Du Clos, “Function of C-reactive protein,” Annals of Medicine, vol. 32, no. 4, pp. 274–278, 2000. View at Google Scholar · View at Scopus
  21. N. Ouchi, S. Kihara, T. Funahashi et al., “Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue,” Circulation, vol. 107, no. 5, pp. 671–674, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. U. N. Das, “Is obesity an inflammatory condition?” Nutrition, vol. 17, no. 11-12, pp. 953–966, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. W. P. Fay, N. Garg, and M. Sunkar, “Vascular functions of the plasminogen activation system,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 6, pp. 1231–1237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Diebold, D. Kraicun, S. Bonello, and A. Görlach, “The ‘PAI-1 paradox’ in vascular remodelling,” Thrombosis and Haemostasis, vol. 100, no. 6, pp. 984–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M.-C. Alessi, M. Poggi, and I. Juhan-Vague, “Plasminogen activator inhibitor-1, adipose tissue and insulin resistance,” Current Opinion in Lipidology, vol. 18, no. 3, pp. 240–245, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Bastelica, P. Morange, B. Berthet et al., “Stromal cells are the main plasminogen activator inhibitor-1–producing cells in human fat: evidence of differences between visceral and subcutaneous deposits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 1, pp. 173–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. N. Fain, A. K. Madan, M. L. Hiler, P. Cheema, and S. W. Bahouth, “Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans,” Endocrinology, vol. 145, no. 5, pp. 2273–2282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Cancello, C. Henegar, N. Viguerie et al., “Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss,” Diabetes, vol. 54, no. 8, pp. 2277–2286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Gazzolo, E. Marinoni, R. Di Iorio et al., “Measurement of urinary S100B protein concentrations for the early identification of brain damage in asphyxiated full-term infants,” Archives of Pediatrics and Adolescent Medicine, vol. 157, no. 12, pp. 1163–1168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. C. W. Heizmann, “Ca2+-binding S100 proteins in the central nervous system,” Neurochemical Research, vol. 24, no. 9, pp. 1097–1100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Gazzolo, R. Di Iorio, E. Marinoni et al., “S100B protein is increased in asphyxiated term infants developing intraventricular hemorrhage,” Critical Care Medicine, vol. 30, no. 6, pp. 1356–1360, 2002. View at Google Scholar · View at Scopus
  32. D. Gazzolo, M. Bruschettini, M. Lituania, G. Serra, E. Gandullia, and F. Michetti, “S100B protein concentrations in urine are correlated with gestational age in healthy preterm and term newborns,” Clinical Chemistry, vol. 47, no. 6, pp. 1132–1133, 2001. View at Google Scholar · View at Scopus
  33. D. Gazzolo, E. Marinoni, R. Di Iorio et al., “Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encephalopathy in asphyxiated full-term infants,” Critical Care Medicine, vol. 32, no. 1, pp. 131–136, 2004. View at Google Scholar · View at Scopus
  34. D. Gazzolo, M. Bruschettini, M. Lituania, G. Serra, W. Bonacci, and F. Michetti, “Incresed urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage,” Clinical Chemistry, vol. 47, no. 10, pp. 1836–1838, 2001. View at Google Scholar · View at Scopus
  35. J. Gardosi, A. Chang, B. Kalyan, D. Sahota, and E. M. Symonds, “Customised antenatal growth charts,” Lancet, vol. 339, no. 8788, pp. 283–287, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Gardosi, M. Mongelli, M. Wilcox, and A. Chang, “An adjustable fetal weight standard,” Ultrasound in Obstetrics & Gynecology, vol. 6, no. 3, pp. 168–174, 1995. View at Google Scholar · View at Scopus
  37. P. Kaminopetros, M. T. Higueras, and K. H. Nicolaides, “Doppler study of uterine artery blood flow: comparison of findings in the first and second trimesters of pregnancy,” Fetal Diagnosis and Therapy, vol. 6, no. 1-2, pp. 58–64, 1991. View at Google Scholar · View at Scopus
  38. G. Acharya, T. Wilsgaard, G. K. R. Berntsen, J. M. Maltau, and T. Kiserud, “Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy,” American Journal of Obstetrics and Gynecology, vol. 192, no. 3, pp. 937–944, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. A. Baschat, H. L. Galan, A. Bhide et al., “Doppler and biophysical assessment in growth restricted fetuses: distribution of test results,” Ultrasound in Obstetrics and Gynecology, vol. 27, no. 1, pp. 41–47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Kyriakakou, A. Malamitsi-Puchner, H. Militsi et al., “Leptin and adiponectin concentrations in intrauterine growth restricted and appropriate for gestational age fetuses, neonates, and their mothers,” European Journal of Endocrinology, vol. 158, no. 3, pp. 343–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Belo, A. Santos-Silva, S. Rocha et al., “Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 123, no. 1, pp. 46–51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. D. H. Watts, M. A. Krohn, M. H. Wener, and D. A. Eschenbach, “C-reactive protein in normal pregnancy,” Obstetrics and Gynecology, vol. 77, no. 2, pp. 176–180, 1991. View at Google Scholar · View at Scopus
  43. F. R. Nielsen, K. M. Bek, P. E. Rasmussen, I. Qvist, and M. Tobiassen, “C-reactive protein during normal pregnancy,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 35, no. 1, pp. 23–27, 1990. View at Google Scholar · View at Scopus
  44. C. Chiesa, F. Signore, M. Assumma et al., “Serial measurements of C-reactive protein and interleukin-6 in the immediate postnatal period: reference intervals and analysis of maternal and perinatal confounders,” Clinical Chemistry, vol. 47, no. 6, pp. 1016–1022, 2001. View at Google Scholar · View at Scopus
  45. M. Ishibashi, Y. Takemura, H. Ishida, K. Watanabe, and T. Kawai, “C-reactive protein kinetics in newborns: application of a high-sensitivity analytic method in its determination,” Clinical Chemistry, vol. 48, no. 7, pp. 1103–1106, 2002. View at Google Scholar · View at Scopus
  46. E. Mathai, U. Christopher, M. Mathai, A. K. Jana, D. Rose, and S. Bergström, “Is C-reactive protein level useful in differentiating infected from uninfected neonates among those at risk of infection?” Indian Pediatrics, vol. 41, no. 9, pp. 895–900, 2004. View at Google Scholar · View at Scopus
  47. Q. Dong and J. R. Wright, “Expression of C-reactive protein by alveolar macrophages,” Journal of Immunology, vol. 156, no. 12, pp. 4815–4820, 1996. View at Google Scholar · View at Scopus
  48. R. Dickie, D. R. Tasat, E. F. Alanis, V. Delfosse, and A. Tsuda, “Age-dependent changes in porcine alveolar macrophage function during the postnatal period of alveolarization,” Developmental and Comparative Immunology, vol. 33, no. 2, pp. 145–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Bastelica, P. Morange, B. Berthet et al., “Stromal cells are the main plasminogen activator inhibitor-1–producing cells in human fat: evidence of differences between visceral and subcutaneous deposits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 1, pp. 173–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. V. Pasceri, J. T. Willerson, and E. T. H. Yeh, “Direct proinflammatory effect of C-reactive protein on human endothelial cells,” Circulation, vol. 102, no. 18, pp. 2165–2168, 2000. View at Google Scholar · View at Scopus
  51. V. Pasceri, J. Chang, J. T. Willerson, and E. T. H. Yeh, “Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs,” Circulation, vol. 103, no. 21, pp. 2531–2534, 2001. View at Google Scholar · View at Scopus
  52. S. Verma, S.-H. Li, M. V. Badiwala et al., “Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein,” Circulation, vol. 105, no. 16, pp. 1890–1896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Devaraj, D. Y. Xu, and I. Jialal, “C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis,” Circulation, vol. 107, no. 3, pp. 398–404, 2003. View at Google Scholar · View at Scopus
  54. S. Guller, Y. Y. Ma, H.-H. Fu, G. Krikun, V. M. Abrahams, and G. Mor, “The placental syncytium and the pathophysiology of preeclampsia and intrauterine growth restriction: a novel assay to assess syncytial protein expression,” Annals of the New York Academy of Sciences, vol. 1127, pp. 129–133, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Salafia and K. Shiverick, “Cigarette smoking and pregnancy. II: vascular effects,” Placenta, vol. 20, no. 4, pp. 273–279, 1999. View at Publisher · View at Google Scholar · View at Scopus
  56. A. E. Quinton, C.-M. Cook, and M. J. Peek, “The relationship between cigarette smoking, endothelial function and intrauterine growth restriction in human pregnancy,” British Journal of Obstetrics and Gynaecology, vol. 115, no. 6, pp. 780–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Gazzolo, F. Michetti, M. Bruschettini et al., “Pediatric concentrations of S100B protein in blood: age- and sex-related changes,” Clinical Chemistry, vol. 49, no. 6, pp. 967–970, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. K. G. Haglid, Q. Yang, A. Hamberger, S. Bergman, A. Widerberg, and N. Danielsen, “S-100β stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants,” Brain Research, vol. 753, no. 2, pp. 196–201, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. F. Michetti and D. Gazzolo, “S100B protein in biological fluids: a tool for perinatal medicine,” Clinical Chemistry, vol. 48, no. 12, pp. 2097–2104, 2002. View at Google Scholar · View at Scopus
  60. C. N. Hales and D. J. P. Barker, “Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis,” Diabetologia, vol. 35, no. 7, pp. 595–601, 1992. View at Publisher · View at Google Scholar · View at Scopus
  61. C. N. Hales and D. J. P. Barker, “The thrifty phenotype hypothesis,” British Medical Bulletin, vol. 60, pp. 5–20, 2001. View at Publisher · View at Google Scholar · View at Scopus
  62. P. Florio, E. Marinoni, R. Di Iorio et al., “Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns,” Pediatrics, vol. 118, no. 3, pp. e747–e754, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Estellés, J. Gilabert, M. Keeton et al., “Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation,” Blood, vol. 84, no. 1, pp. 143–150, 1994. View at Google Scholar · View at Scopus
  64. B. L. Sheppard and J. Bonnar, “Uteroplacental hemostasis in intrauterine fetal growth retardation,” Seminars in Thrombosis and Hemostasis, vol. 25, no. 5, pp. 443–446, 1999. View at Google Scholar · View at Scopus
  65. A. O. Odibo, D. Nelson, D. M. Stamilio, H. M. Sehdev, and G. A. Macones, “Advanced maternal age is an independent risk factor for intrauterine growth restriction,” American Journal of Perinatology, vol. 23, no. 5, pp. 325–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. K. Duckitt and D. Harrington, “Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies,” British Medical Journal, vol. 330, no. 7491, pp. 565–567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. E. J. Kongnyuy, P. N. Nana, N. Fomulu, S. C. Wiysonge, L. Kouam, and A. S. Doh, “Adverse perinatal outcomes of adolescent pregnancies in Cameroon,” Maternal and Child Health Journal, vol. 12, no. 2, pp. 149–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. I. M. Usta, D. Zoorob, A. Abu-Musa, G. Naassan, and A. H. Nassar, “Obstetric outcome of teenage pregnancies compared with adult pregnancies,” Acta Obstetricia et Gynecologica Scandinavica, vol. 87, no. 2, pp. 178–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  69. M. H. Aliyu, S. Luke, S. Kristensen, A. P. Alio, and H. M. Salihu, “Joint effect of obesity and teenage pregnancy on the risk of preeclampsia: a population-based study,” Journal of Adolescent Health, vol. 46, no. 1, pp. 77–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. T. O. Lawoyin and F. A. Ani, “Epidemiologic aspects of pre-eclampsia in Saudi Arabia,” East African Medical Journal, vol. 73, no. 6, pp. 404–406, 1996. View at Google Scholar · View at Scopus
  71. H. S. Ros, S. Cnattingius, and L. Lipworth, “Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study,” American Journal of Epidemiology, vol. 147, no. 11, pp. 1062–1070, 1998. View at Google Scholar · View at Scopus
  72. C.-J. Lee, T.-T. Hsieh, T.-H. Chiu, K.-C. Chen, L.-M. Lo, and T.-H. Hung, “Risk factors for pre-eclampsia in an Asian population,” International Journal of Gynecology and Obstetrics, vol. 70, no. 3, pp. 327–333, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. A. Clerico, M. G. Del Chicca, M. Ferdeghini, S. Ghione, and F. Materazzi, “Progressively elevated levels of biologically active (free) cortisol during pregnancy by a direct radioimmunological assay of diffusible cortisol in an equilibrium dialysis system,” Journal of Endocrinological Investigation, vol. 3, no. 2, pp. 185–187, 1980. View at Google Scholar · View at Scopus
  74. M. Dalle, P. Pradier, and P. Delost, “The regulation of glucocorticosteroid secretion during the perinatal period,” Reproduction Nutrition Developpement, vol. 25, no. 5, pp. 977–991, 1985. View at Google Scholar · View at Scopus
  75. M. Bruschettini, D. L. A. van den Hove, D. Gazzolo, P. Bruschettini, C. E. Blanco, and H. W. M. Steinbusch, “A single course of antenatal betamethasone reduces neurotrophic factor S100B concentration in the hippocampus and serum in the neonatal rat,” Developmental Brain Research, vol. 159, no. 2, pp. 113–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. D. L. A. Van den Hove, H. W. M. Steinbusch, M. Bruschettini et al., “Prenatal stress reduces S100B in the neonatal rat hippocampus,” NeuroReport, vol. 17, no. 10, pp. 1077–1080, 2006. View at Publisher · View at Google Scholar · View at Scopus